Acute Cerebral Infarction Patients Face Increased Risk
When Blood Pressure Is Kept Too Low After Arterial Recanalization Therapy

Hyoseok Nam, Professor of Neurology at Severance Hospital, recently led the revision of the acute cerebral infarction treatment guidelines issued by the American Heart Association and the Korean Stroke Society.


According to Yonsei University Health System on November 20, acute cerebral infarction is a condition in which a blood clot blocks a cerebral blood vessel, reducing the supply of blood and oxygen and causing brain damage. Since brain damage can result in severe aftereffects such as hemiplegia or language disorders, it is critical to restore blood flow as quickly as possible.

Hyoseok Nam, Professor of Neurology, Severance Hospital, Yonsei University Health System

Hyoseok Nam, Professor of Neurology, Severance Hospital, Yonsei University Health System

View original image

If there is a large amount of thrombus, endovascular recanalization therapy is performed by inserting a catheter into the artery to remove the clot. After successful recanalization, it is important to manage systolic (maximum) blood pressure to prevent cerebral hemorrhage caused by excessive blood flow through the cerebral vessels.


Prior to this guideline revision, both American and European treatment guidelines recommended maintaining systolic blood pressure below 180 mmHg after arterial recanalization therapy. However, most retrospective studies had shown that controlling blood pressure to a level lower than 180 mmHg led to better patient outcomes, and in actual clinical practice, lower target blood pressures were often used.


In 2023, Professor Nam's team published the results of a randomized clinical trial in the Journal of the American Medical Association (JAMA), which showed that when blood pressure in acute cerebral infarction patients who had undergone arterial recanalization therapy was controlled to a level much lower than the guideline (below 180 mmHg), specifically below 140 mmHg, the risk of poor outcomes increased by 1.84 times.


Based on these findings, the American Heart Association and the Korean Stroke Society revised their 2025 treatment guidelines to include a warning that managing blood pressure below 140 mmHg in acute cerebral infarction patients who have undergone arterial recanalization therapy is dangerous, thereby emphasizing patient safety. The level of evidence for the added guideline was the highest grade, Level A from the American Heart Association and Level Ia from the Korean Stroke Society.



Professor Nam stated, "The results of our randomized clinical trial, which showed that excessively lowering blood pressure after arterial recanalization therapy is dangerous, have led to changes in the clinical guidelines," adding, "Since maintaining systolic blood pressure below 140 mmHg after successful recanalization therapy has been shown to be risky, the target range should be considered as 140-180 mmHg."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing